Clinical Trial Update: A Phase 3 Study of NE3107 in Probable Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of NE3107 for probable Alzheimer's disease completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• NE3107 (NE3107)

Snippet

Sponsor: BioVie Inc. | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED